Related by context. Frequent words. (Click for all words.) 64 phase IIa 63 multicenter clinical 63 Phase 2a clinical 63 Phase 1b clinical 62 Phase IIa clinical 62 placebo controlled clinical 62 Phase 1b trial 62 confirmatory Phase III 62 Phase IIb clinical 61 phase IIb 60 Azedra 60 phase 2a 60 Phase 1a 59 tanespimycin 59 pharmacodynamic effects 59 dose escalation trial 59 Phase IIa trial 59 Phase 2b study 59 Phase 2b clinical 59 Phase Ib 59 Phase 2a trial 58 axitinib 58 Phase 2b trial 58 registrational 58 confirmatory Phase 3 58 Phase Ia 58 pertuzumab 58 randomized Phase III 57 IIa clinical trial 57 deforolimus 57 RGB # 57 Phase 2a 57 Sym# 57 unblinding 57 placebo controlled randomized 57 Phase III clinical 57 IND submission 57 Phase III 57 Phase IIb 57 CR# vcMMAE 57 Laquinimod 57 randomized controlled clinical 57 Allovectin 7 R 57 anticancer compound 56 Asentar 56 safety tolerability pharmacokinetics 56 Phase II 56 eniluracil 56 PXD# 56 registrational trial 56 Phase 2b 56 IMC A# 56 multiple ascending dose 56 Phase IIa 56 prospective randomized controlled 56 HGS ETR1 56 Phase 1b 56 SCH # 55 IND enabling 55 cangrelor 55 CA4P 55 double blinded placebo 55 ataluren 55 pharmacokinetic properties 55 Phase III randomized 55 thymalfasin 55 Cloretazine R VNP#M 55 CYT# 55 Preclinical studies 55 RG# [001] 54 anti fibrotic 54 preclinical toxicology 54 DAVANAT 54 TELCYTA 54 Phase III pivotal 54 Phase IIb trial 54 GV# [001] 54 genotoxicity 54 ThermoDox ® 54 MOZOBIL 54 BAY #-# 54 TASQ 54 PREOS 54 tesmilifene 54 noninferiority 54 Neuradiab 54 Carfilzomib 54 PF # [001] 54 pafuramidine 54 topical formulation 54 tolerated dose MTD 53 ICA # 53 Ostarine 53 Amrubicin 53 AP# [003] 53 teduglutide 53 MDV# 53 AZD# 53 KNS # 53 preclinical 53 ATTRACT